• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

图(L.)叶茶对轻度特应性皮炎成人的疗效和安全性:一项双盲、随机、安慰剂对照初探试验。

Efficacy and Safety of Fig ( L.) Leaf Tea in Adults with Mild Atopic Dermatitis: A Double-Blind, Randomized, Placebo-Controlled Preliminary Trial.

机构信息

Toyo Institute of Food Technology, 23-2, 4-Chome, Minami-Hanayashiki, Kawanishi 666-0026, Hyogo, Japan.

出版信息

Nutrients. 2022 Oct 25;14(21):4470. doi: 10.3390/nu14214470.

DOI:10.3390/nu14214470
PMID:36364740
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9658579/
Abstract

Atopic dermatitis (AD) is a chronic, recurrent pruritic skin disease with repeated remissions and exacerbations. Various factors, such as allergies, skin conditions and lifestyle, combine to cause AD, making it difficult to cure completely. Although AD symptoms are suppressed with medications, this is a long-term effort and burden on patients. Thus, safer drugs and alternatives are needed. We previously found that consumption of tea prepared from fig ( L.) leaves alleviated allergy and AD symptoms in cultured cells and animals. Therefore, here, we conducted a double-blind, randomized, controlled study in patients with mild AD to evaluate the safety and AD-relieving effects of prolonged consumption of fig leaf tea. Positive effects of fig leaf tea consumption were confirmed in 14 of 15 participants. Eczema Area and Severity Index values were significantly lowered in the fig leaf tea-treated group than in the placebo-treated group. The effect weakened 4 weeks after the end of the intervention, suggesting that continued intake of fig leaf tea was effective. Further assessments confirmed the safety of fig leaf tea consumption and revealed no variations that might pose a health hazard. Therefore, we postulate that fig leaf tea is a natural and safe therapeutic option for AD.

摘要

特应性皮炎(AD)是一种慢性、复发性瘙痒性皮肤病,有反复发作和缓解的特点。过敏、皮肤状况和生活方式等各种因素共同作用导致 AD,使其难以完全治愈。尽管药物可以抑制 AD 症状,但这需要患者长期努力和承受负担。因此,需要更安全的药物和替代方法。我们之前发现,食用由无花果(L.)叶制成的茶可以减轻过敏和 AD 症状在培养细胞和动物中的作用。因此,在这里,我们在患有轻度 AD 的患者中进行了一项双盲、随机、对照研究,以评估长期饮用无花果叶茶的安全性和缓解 AD 的效果。在 15 名参与者中,有 14 名确认了无花果叶茶的积极作用。与安慰剂组相比,无花果叶茶治疗组的湿疹面积和严重程度指数(Eczema Area and Severity Index,EASI)显著降低。干预结束 4 周后,效果减弱,这表明持续摄入无花果叶茶是有效的。进一步的评估证实了无花果叶茶的安全性,没有发现可能对健康构成危害的变化。因此,我们推测无花果叶茶是 AD 的一种天然且安全的治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e271/9658579/b4e42bd189c1/nutrients-14-04470-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e271/9658579/b4e42bd189c1/nutrients-14-04470-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e271/9658579/b4e42bd189c1/nutrients-14-04470-g002.jpg

相似文献

1
Efficacy and Safety of Fig ( L.) Leaf Tea in Adults with Mild Atopic Dermatitis: A Double-Blind, Randomized, Placebo-Controlled Preliminary Trial.图(L.)叶茶对轻度特应性皮炎成人的疗效和安全性:一项双盲、随机、安慰剂对照初探试验。
Nutrients. 2022 Oct 25;14(21):4470. doi: 10.3390/nu14214470.
2
A new topical treatment of atopic dermatitis in pediatric patients based on Ficus carica L. (Fig): A randomized, placebo-controlled clinical trial.基于无花果(Ficus carica L.)的儿童特应性皮炎新局部治疗:一项随机、安慰剂对照临床试验。
Complement Ther Med. 2017 Dec;35:85-91. doi: 10.1016/j.ctim.2017.10.003. Epub 2017 Oct 13.
3
Fig ( L.) leaf tea suppresses allergy by acceleration disassembly of IgE-receptor complexes.桑叶茶通过加速 IgE 受体复合物的解体来抑制过敏。
Biosci Biotechnol Biochem. 2020 May;84(5):1013-1022. doi: 10.1080/09168451.2020.1722608. Epub 2020 Jan 27.
4
Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.度普利尤单抗联合局部皮质类固醇治疗青少年和成人中重度特应性皮炎(AD Up)的安全性和有效性:一项随机、双盲、安慰剂对照、3 期临床试验的结果。
Lancet. 2021 Jun 5;397(10290):2169-2181. doi: 10.1016/S0140-6736(21)00589-4. Epub 2021 May 21.
5
Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE).度普利尤单抗治疗青少年中重度特应性皮炎的长期疗效和安全性:III 期开放标签扩展试验(LIBERTY AD PED-OLE)的第 52 周结果。
Am J Clin Dermatol. 2022 May;23(3):365-383. doi: 10.1007/s40257-022-00683-2. Epub 2022 May 14.
6
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials.每日一次乌帕替尼对比安慰剂治疗中重度特应性皮炎青少年和成人患者(Measure Up1 和 Measure Up2):两项复制性、双盲、随机对照 3 期临床试验结果。
Lancet. 2021 Jun 5;397(10290):2151-2168. doi: 10.1016/S0140-6736(21)00588-2. Epub 2021 May 21.
7
Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.在一项开放性研究中,度普利尤单抗为中重度特应性皮炎成人患者提供了长达 4 年的可接受安全性和持续疗效。
Am J Clin Dermatol. 2022 May;23(3):393-408. doi: 10.1007/s40257-022-00685-0. Epub 2022 May 3.
8
Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.湿疹和特应性皮炎患者金黄色葡萄球菌皮肤定植及相关联合局部治疗:一项双盲多中心随机对照试验
Br J Dermatol. 2006 Oct;155(4):680-7. doi: 10.1111/j.1365-2133.2006.07410.x.
9
Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo-controlled, phase III clinical trial (BREEZE-AD4).巴瑞替尼联合局部皮质类固醇治疗对环孢素反应不足、不耐受或禁忌的中重度特应性皮炎患者的疗效和安全性:一项随机、安慰剂对照、III 期临床试验(BREEZE-AD4)的结果。
Br J Dermatol. 2022 Sep;187(3):338-352. doi: 10.1111/bjd.21630. Epub 2022 Jul 20.
10
The Chinese herbal formula Huoxiang Zhengqi for atopic dermatitis with dampness pattern (CHARM): a study protocol for a double-blinded randomized controlled trial.《香薷正芪方治疗湿热型特应性皮炎的临床研究方案》:一项双盲随机对照试验
Trials. 2021 Jan 19;22(1):67. doi: 10.1186/s13063-020-05014-6.

引用本文的文献

1
A Comprehensive Systematic Review of Natural Biomedicines for Immune-Mediated and Inflammatory Dermatologic Diseases.免疫介导性和炎症性皮肤病天然生物药物的综合系统评价
Clin Drug Investig. 2025 May;45(5):255-270. doi: 10.1007/s40261-025-01441-y. Epub 2025 Apr 28.
2
Isoschaftoside in Fig Leaf Tea Alleviates Nonalcoholic Fatty Liver Disease in Mice via the Regulation of Macrophage Polarity.无花果叶茶中的异荭草苷通过调节巨噬细胞极化减轻小鼠非酒精性脂肪性肝病。
Nutrients. 2025 Feb 21;17(5):757. doi: 10.3390/nu17050757.
3
Exploring Genetic Association of Tea Intake With Allergic Diseases Among European Population: A Bidirectional Mendelian Randomization Study.

本文引用的文献

1
Comparative anticancer activities of and latex in MDA-MB-231 cells.[具体物质名称]和[具体物质名称]乳胶对MDA-MB-231细胞的抗癌活性比较
Saudi J Biol Sci. 2021 Jun;28(6):3225-3234. doi: 10.1016/j.sjbs.2021.02.061. Epub 2021 Feb 24.
2
Tacrolimus ointment in the treatment of hormone-dependent dermatitis: A protocol of systematic review.他克莫司软膏治疗激素依赖性皮炎:一项系统评价方案
Medicine (Baltimore). 2020 Sep 11;99(37):e22159. doi: 10.1097/MD.0000000000022159.
3
Ficus carica polysaccharide attenuates DSS-induced ulcerative colitis in C57BL/6 mice.
探索欧洲人群中茶摄入量与过敏性疾病的遗传关联:一项双向孟德尔随机化研究。
Food Sci Nutr. 2024 Nov 1;12(12):10223-10230. doi: 10.1002/fsn3.4574. eCollection 2024 Dec.
4
Dietary Interventions in Atopic Dermatitis: A Comprehensive Scoping Review and Analysis.饮食干预在特应性皮炎中的应用:全面的范围综述与分析。
Int Arch Allergy Immunol. 2024;185(6):545-589. doi: 10.1159/000535903. Epub 2024 Mar 5.
5
In Vitro and In Vivo Anti-Psoriasis Activity of Fruit Extracts via JAK-STAT Modulation.水果提取物通过JAK-STAT调节的体外和体内抗银屑病活性
Life (Basel). 2023 Jul 31;13(8):1671. doi: 10.3390/life13081671.
软枣猕猴桃多糖减轻 C57BL/6 小鼠实验性溃疡性结肠炎。
Food Funct. 2020 Jul 1;11(7):6666-6679. doi: 10.1039/d0fo01162b. Epub 2020 Jul 13.
4
Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study.地夸磷索钠滴眼液治疗干眼病的有效性和安全性的 Meta 分析
J Am Acad Dermatol. 2020 Apr;82(4):823-831. doi: 10.1016/j.jaad.2019.12.015. Epub 2020 Feb 3.
5
Fig ( L.) leaf tea suppresses allergy by acceleration disassembly of IgE-receptor complexes.桑叶茶通过加速 IgE 受体复合物的解体来抑制过敏。
Biosci Biotechnol Biochem. 2020 May;84(5):1013-1022. doi: 10.1080/09168451.2020.1722608. Epub 2020 Jan 27.
6
Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis: The ADAPT Randomized Clinical Trial.奥马珠单抗治疗重度小儿特应性皮炎的效果:ADAPT随机临床试验
JAMA Pediatr. 2020 Jan 1;174(1):29-37. doi: 10.1001/jamapediatrics.2019.4476.
7
Clinical practice guidelines for the management of atopic dermatitis 2018.2018 年特应性皮炎管理临床实践指南。
J Dermatol. 2019 Dec;46(12):1053-1101. doi: 10.1111/1346-8138.15090. Epub 2019 Oct 9.
8
Umbelliferone reduces the expression of inflammatory chemokines in HaCaT cells and DNCB/DFE-induced atopic dermatitis symptoms in mice.茵陈黄酮可降低 HaCaT 细胞中炎症趋化因子的表达,并减轻 DNCB/DFE 诱导的小鼠特应性皮炎症状。
Int Immunopharmacol. 2019 Oct;75:105830. doi: 10.1016/j.intimp.2019.105830. Epub 2019 Aug 19.
9
Anticancer Activity of Methanol Extract of Leaves and Fruits Against Proliferation, Apoptosis, and Necrosis in Huh7it Cells.叶片和果实甲醇提取物对Huh7it细胞增殖、凋亡及坏死的抗癌活性
Cancer Inform. 2019 Apr 19;18:1176935119842576. doi: 10.1177/1176935119842576. eCollection 2019.
10
Plasma Dynorphin A Concentration Reflects the Degree of Pruritus in Chronic Liver Disease: A Preliminary Report.血浆强啡肽A浓度反映慢性肝病瘙痒程度:初步报告
Acta Derm Venereol. 2019 Apr 1;99(4):442-443. doi: 10.2340/00015555-3139.